About
Pulmatrix Inc (NASDAQ:PULM) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger
Mar 26 2026
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
Mar 2 2026
Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities
Feb 26 2026
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results
Dec 18 2025
Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives
Financials
Revenue
$3 K
Market Cap
$4.78 M
EPS
-1.41
Google Übersetzer